SARACENO, ROSITA
 Distribuzione geografica
Continente #
NA - Nord America 14.527
EU - Europa 1.384
AS - Asia 1.309
SA - Sud America 214
AF - Africa 31
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.487
Nazione #
US - Stati Uniti d'America 14.489
SG - Singapore 514
CN - Cina 456
DE - Germania 223
UA - Ucraina 212
IT - Italia 198
BR - Brasile 176
IE - Irlanda 135
HK - Hong Kong 129
FR - Francia 115
SE - Svezia 113
RU - Federazione Russa 98
GB - Regno Unito 92
FI - Finlandia 57
PL - Polonia 56
KR - Corea 50
IN - India 36
VN - Vietnam 35
CA - Canada 26
AU - Australia 16
AE - Emirati Arabi Uniti 13
AR - Argentina 13
CO - Colombia 12
EG - Egitto 12
SK - Slovacchia (Repubblica Slovacca) 12
ES - Italia 11
BD - Bangladesh 10
JP - Giappone 10
ZA - Sudafrica 9
CH - Svizzera 8
IR - Iran 8
KG - Kirghizistan 8
NL - Olanda 8
BE - Belgio 7
MX - Messico 7
RO - Romania 7
AT - Austria 6
IQ - Iraq 6
MA - Marocco 6
PY - Paraguay 6
TR - Turchia 6
UZ - Uzbekistan 5
GR - Grecia 4
LT - Lituania 4
LV - Lettonia 4
PT - Portogallo 4
RS - Serbia 4
CZ - Repubblica Ceca 3
EU - Europa 3
ID - Indonesia 3
PH - Filippine 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DZ - Algeria 2
EC - Ecuador 2
IL - Israele 2
NI - Nicaragua 2
OM - Oman 2
PK - Pakistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
Totale 17.487
Città #
Woodbridge 4.102
Houston 3.739
Wilmington 3.344
Fairfield 454
Ann Arbor 348
Chandler 320
Singapore 293
Ashburn 270
Jacksonville 185
Cambridge 166
Beijing 162
Seattle 161
Dublin 135
Hong Kong 125
Medford 109
New York 103
Zhengzhou 92
Dearborn 90
Rome 67
The Dalles 66
Lawrence 50
Dallas 48
Santa Clara 46
Los Angeles 44
Kraków 35
Shanghai 34
Boardman 30
Menlo Park 25
Buffalo 23
San Diego 21
Moscow 19
São Paulo 19
Redondo Beach 18
Council Bluffs 17
Munich 17
Mülheim 17
Hefei 16
Norwalk 15
Hangzhou 14
Ho Chi Minh City 13
Nanjing 13
Redwood City 13
Dubai 11
Guangzhou 11
London 11
Milan 10
Warsaw 10
Brooklyn 9
Detroit 9
Hanoi 9
Kunming 8
Montreal 8
Toronto 8
Denver 7
Nanchang 7
Palo Alto 7
Paris 7
Redmond 7
San Mateo 7
Brussels 6
Chennai 6
Chicago 6
Columbus 6
Helsinki 6
Johannesburg 6
Orem 6
Poznan 6
Bern 5
Bolzano 5
Dhaka 5
Fuzhou 5
Melbourne 5
Mountain View 5
San Jose 5
Stockholm 5
Tokyo 5
Trento 5
Turku 5
University Park 5
Verona 5
Wuhan 5
Ankara 4
Asunción 4
Auburn Hills 4
Baghdad 4
Cairo 4
Carinaro 4
Florence 4
Jinan 4
Mexico City 4
Nuremberg 4
Nîmes 4
Nürnberg 4
Riga 4
San Francisco 4
Seoul 4
Bengaluru 3
Brno 3
Cabo Frio 3
Campinas 3
Totale 15.214
Nome #
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.381
Efficacy and safety of infliximab in psoriatic patients over the age of 65 528
Atopic dermatitis and dental manifestations 524
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 464
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 458
Topical lactoferrin can improve stable psoriatic plaque 454
Apremilast for the treatment of psoriasis. 453
New topical treatments for psoriasis 447
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 441
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 439
Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target? 432
Oral lichen planus: therapy and phenotype 431
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 430
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 429
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 427
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 427
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 426
The significance of the development of antinuclear antibodies during infliximab treatment 423
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 405
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 400
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 392
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 388
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 383
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 378
Erysipeloid cutaneous metastasis from bladder carcinoma 375
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 375
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 372
Prevalence and management of panic attacks during infliximab infusion in psoriatic patients 369
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 366
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 356
Does metabolic syndrome influence psoriasis? 348
The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study 346
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 345
Tofacitinib for the treatment of moderate-to-severe psoriasis 343
Safety evaluation of apremilast for the treatment of psoriasis 307
Why 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis? 306
A European perspective on the challenges of managing psoriasis 207
Oral lichen planus: Therapy and phenotype 196
308 nm monochromatic excimer light in the treatment of psoriasis 182
Different applications of monochromatic excimer light in skin diseases 171
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides 156
Treatment of folliculitis with monochromatic excimer light (308 nm). 152
Type III juvenile pityriasis rubra pilaris: A successful treatment with infliximab [12] 140
Randomized, within-patient, clinical trial comparing fluorine-synthetic fiber socks with standard cotton socks in improving plantar pustulosis 140
Aphthous, coeliac disease and other dental disorders in childhood 140
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. 137
Nanomedicine in dermatology: Benefits and emerging applications 119
Comparison of a novel treatment protocol with oral fluconazole vs probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 in the treatment of recurrent vulvovaginal candidiasis 112
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases 95
Clinical severity instruments 86
Keratosis punctata palmoplantaris and malignancies: case report 72
Apheresis in the treatment of recalcitrant atopic dermatitis: Case series and review of the literature 53
Totale 17.726
Categoria #
all - tutte 39.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021882 0 0 0 0 0 188 251 188 81 47 104 23
2021/2022533 32 59 41 34 14 54 23 21 40 56 28 131
2022/2023815 70 63 37 119 87 153 56 48 98 11 39 34
2023/2024345 34 8 37 18 26 104 21 13 2 7 10 65
2024/2025980 47 193 106 77 34 58 102 36 74 96 98 59
2025/2026893 166 95 239 184 196 13 0 0 0 0 0 0
Totale 17.726